NCT03599726View on ClinicalTrials.gov

Improving Walking Automaticity in Parkinson's Disease: Levodopa or Donepezil

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

July 30, 2018

Primary Completion Date

May 30, 2019

Study Completion Date

July 30, 2019

Conditions
Parkinson Disease
Interventions
DRUG

Donepezil

Donepezil 5 mg per day for week 1-2 or 5-6

DRUG

Placebo

Placebo 5 mg per day for week 1-2 or 5-6

Trial Locations (1)

97239

Oregon Health & Science University, Portland

All Listed Sponsors
collaborator

Medical Research Foundation, Oregon

OTHER

lead

Oregon Health and Science University

OTHER

NCT03599726 - Improving Walking Automaticity in Parkinson's Disease: Levodopa or Donepezil | Biotech Hunter | Biotech Hunter